Comparison Between the Clinical Effect of Percutaneous Kyphoplasty for Osteoporosis Vertebral Compression Fracture Patient with or Without Sarcopenia: A Retrospective Cohort Study

References

• Zheng XQ, Xu L, Huang J, et al. Incidence and cost of vertebral fracture in urban China: a five-year population-based cohort study. Int J Surg. 2023. doi:10.1097/js9.0000000000000411
   Web of Science ®Google Scholar
• Choi SH, Kim DY, Koo JW, Lee SG, Jeong SY, Kang CN. Incidence and management trends of osteoporotic vertebral compression fractures in South Korea: a nationwide population-based study. Asian Spine J. 2020;14:220–228. doi:10.31616/asj.2019.0051
   PubMed Web of Science ®Google Scholar
• Cauley JA, Palermo L, Vogt M, et al. Prevalent vertebral fractures in black women and white women. J Bone Miner Res. 2008;23:1458–1467. doi:10.1359/jbmr.080411
   PubMed Web of Science ®Google Scholar
• Hopkins TJ, Eggington S, Quinn M, Nichols-Ricker CI. Cost-effectiveness of balloon kyphoplasty and vertebroplasty versus conservative medical management in the USA. Osteoporos Int. 2020;31:2461–2471. doi:10.1007/s00198-020-05513-x
   PubMed Web of Science ®Google Scholar
• Patel N, Jacobs D, John J, et al. Balloon kyphoplasty vs vertebroplasty: a systematic review of height restoration in osteoporotic vertebral compression fractures. J Pain Res. 2022;15:1233–1245. doi:10.2147/jpr.S344191
   PubMed Web of Science ®Google Scholar
• Ge C, Chen Z, Cao P. Efficacy of percutaneous kyphoplasty on vertebral compression fractures with different bone mineral densities: a retrospective study. BMC Musculoskelet Disord. 2023;24:276. doi:10.1186/s12891-023-06341-w
   PubMed Web of Science ®Google Scholar
• Yu H, Luo G, Wang Z, Yu B, Sun T, Tang Q. Predictors of residual low back pain in patients with osteoporotic vertebral fractures following percutaneous kyphoplasty. Front Surg. 2023;10:1119393. doi:10.3389/fsurg.2023.1119393
   PubMed Web of Science ®Google Scholar
• Li YX, Guo DQ, Zhang SC, et al. Risk factor analysis for re-collapse of cemented vertebrae after percutaneous vertebroplasty (PVP) or percutaneous kyphoplasty (PKP). Int Orthop. 2018;42:2131–2139. doi:10.1007/s00264-018-3838-6
   PubMed Web of Science ®Google Scholar
• Beaudart C, Demonceau C, Reginster JY, et al. Sarcopenia and health-related quality of life: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2023;14:1228–1243. doi:10.1002/jcsm.13243
   PubMed Web of Science ®Google Scholar
• Bo J, Zhao X, Hua Z, Li J, Qi X, Shen Y. Impact of sarcopenia and sagittal parameters on the residual back pain after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fracture. J Orthop Surg Res. 2022;17:111. doi:10.1186/s13018-022-03009-4
   PubMed Web of Science ®Google Scholar
• Chen Q, Lei C, Zhao T, et al. Relationship between sarcopenia/paravertebral muscles and the incidence of vertebral refractures following percutaneous kyphoplasty: a retrospective study. BMC Musculoskelet Disord. 2022;23:879. doi:10.1186/s12891-022-05832-6
   PubMed Web of Science ®Google Scholar
• Wang WF, Lin CW, Xie CN, et al. The association between sarcopenia and osteoporotic vertebral compression refractures. Osteoporos Int. 2019;30:2459–2467. doi:10.1007/s00198-019-05144-x
   PubMed Web of Science ®Google Scholar
• Zhou X, Meng X, Zhu H, Zhu Y, Yuan W. Early versus late percutaneous kyphoplasty for treating osteoporotic vertebral compression fracture: a retrospective study. Clin Neurol Neurosurg. 2019;180:101–105. doi:10.1016/j.clineuro.2019.03.029
   PubMed Web of Science ®Google Scholar
• Macnab I. Negative disc exploration. An analysis of the causes of nerve-root involvement in sixty-eight patients. J Bone Joint Surg Am. 1971;53:891–903. doi:10.2106/00004623-197153050-00004
   PubMed Web of Science ®Google Scholar
• Hacker UT, Hasenclever D, Linder N, et al. Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trial. J Cachexia Sarcopenia Muscle. 2020;11:135–144. doi:10.1002/jcsm.12484
   PubMed Web of Science ®Google Scholar
• Evans WJ, Campbell WW. Sarcopenia and age-related changes in body composition and functional capacity. J Nutr. 1993;123:465–468. doi:10.1093/jn/123.suppl_2.465
   PubMed Web of Science ®Google Scholar
• Vidal-Cuellar CL, Mas G, Ayamamani-Torres P, Yazawa T, Rosas-Carrasco O, Tello T. Identification of Probable sarcopenia based on SARC-F and SARC-CalF in older adults from a low-resource setting. J Frailty Sarcopenia Falls. 2022;7:222–230. doi:10.22540/jfsf-07-222
   PubMedGoogle Scholar
• Alexandre Tda S, Duarte YA, Santos JL, Wong R, Lebrão ML. Sarcopenia according to the European Working Group on Sarcopenia in Older People (EWGSOP) versus dynapenia as a risk factor for mortality in the elderly. J Nutr Health Aging. 2014;18:751–756. doi:10.1007/s12603-014-0540-2
   PubMed Web of Science ®Google Scholar
• Cui C, Bao Z, Chow SK, et al. Coapplication of magnesium supplementation and vibration modulate macrophage polarization to attenuate sarcopenic muscle atrophy through PI3K/Akt/mTOR signaling pathway. Int J Mol Sci. 2022;23:12944. doi:10.3390/ijms232112944
   PubMed Web of Science ®Google Scholar
• An HJ, Tizaoui K, Terrazzino S, et al. Sarcopenia in autoimmune and rheumatic diseases: a comprehensive review. Int J Mol Sci. 2020;21:5678. doi:10.3390/ijms21165678
   PubMed Web of Science ®Google Scholar
• Zhang Y, Dilixiati Y, Jiang W, Cao X, Chen Y, Guo H. Correlation of psoas muscle index with fragility vertebral fracture: a retrospective cross-sectional study of middle-aged and elderly women. Int J Endocrinol. 2022;2022:4149468. doi:10.1155/2022/4149468
   PubMed Web of Science ®Google Scholar
• Kajiki Y, Tsuji H, Misawa H, et al. Psoas muscle index predicts osteoporosis and fracture risk in individuals with degenerative spinal disease. Nutrition. 2022;93:111428. doi:10.1016/j.nut.2021.111428
   PubMed Web of Science ®Google Scholar
• Chen M, Yang C, Cai Z, et al. Lumbar posterior group muscle degeneration: influencing factors of adjacent vertebral body re-fracture after percutaneous vertebroplasty. Front Med. 2022;9:1078403. doi:10.3389/fmed.2022.1078403
   Web of Science ®Google Scholar
• Gao X, Du J, Hao D, He B, Yan L. Risk factors for residual back pain following percutaneous vertebral augmentation: the importance of paraspinal muscle fatty degeneration. Int Orthop. 2023;47:1797–1804. doi:10.1007/s00264-023-05809-7
   PubMed Web of Science ®Google Scholar
• Lidar S, Salame K, Chua M, et al. Sarcopenia is an independent risk factor for subsequent osteoporotic vertebral fractures following percutaneous cement augmentation in elderly patients. J Clin Med. 2022;11:5778. doi:10.3390/jcm11195778
   PubMed Web of Science ®Google Scholar
• Osterhoff G, Asatryan G, Spiegl UJA, Pfeifle C, Jarvers JS, Heyde CE. Impact of multifidus muscle atrophy on the occurrence of secondary symptomatic adjacent osteoporotic vertebral compression fractures. Calcif Tissue Int. 2022;110:421–427. doi:10.1007/s00223-021-00925-1
   PubMed Web of Science ®Google Scholar
• Bayram S, Akgül T, Adıyaman AE, Karalar Ş, Dölen D, Aydoseli A. Effect of sarcopenia on mortality after percutaneous vertebral augmentation treatment for osteoporotic vertebral compression fractures in elderly patients: a retrospective cohort study. World Neurosurg. 2020;138:e354–e360. doi:10.1016/j.wneu.2020.02.121
   PubMed Web of Science ®Google Scholar
• He C, He W, Hou J, et al. Bone and muscle crosstalk in aging. Front Cell Dev Biol. 2020;8:585644. doi:10.3389/fcell.2020.585644
   PubMed Web of Science ®Google Scholar
• Gibbons D, McDonnell JM, Ahern DP, et al. The relationship between radiological paraspinal lumbar measures and clinical measures of sarcopenia in older patients with chronic lower back pain. J Frailty Sarcopenia Falls. 2022;7:52–59. doi:10.22540/jfsf-07-052
   PubMedGoogle Scholar